Mint Tower Capital Management B.V. Amgen Inc Transaction History

Mint Tower Capital Management B.V.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$229.03 - $291.01 $682,738 - $867,500	-2,981 Reduced 67.15%	1,458 $383,000
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $996,377 - $1.12 Million	4,439 New	4,439 $1 Million
Q2 2020 Aug 06, 2020	SELL	$197.81 - $242.74 $117,301 - $143,944	-593 Closed	0 $0
Q1 2020 May 13, 2020	SELL	$182.24 - $241.7 $247,299 - $327,986	-1,357 Reduced 69.59%	593 $120,000
Q1 2018 May 09, 2018	BUY	$169.43 - $198.0 $330,388 - $386,100	1,950 New	1,950 $332,000

3,075

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Mint Tower Capital Management B.V., based on Form 13F filings with the SEC.

Stay updated on Mint Tower Capital Management B.V. with notifications on news.